Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Boyle EM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 33
Tytuł:
B-cell malignancies: capture-sequencing strategies for identification of gene rearrangements and translocations into immunoglobulin gene loci
Autorzy:
Boyle EM
Walker BA
Wardell CP
Leleu X
Davies FE
Morgan GJ
Pokaż więcej
Temat:
Diseases of the blood and blood-forming organs
RC633-647.5
Źródło:
Blood and Lymphatic Cancer: Targets and Therapy, Vol 2014, Iss default, Pp 107-119 (2014)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/b-cell-malignancies-capture-sequencing-strategies-for-identification-o-peer-reviewed-article-BLCTT; https://doaj.org/toc/1179-9889
Dostęp URL:
https://doaj.org/article/c558238f6afb459aac117e4ae0fcf9a3  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Changes in management policies for extremely preterm births and neonatal outcomes from 2003 to 2012: two population-based studies in ten European regions.
Autorzy:
Bonet, M
Cuttini, M
Piedvache, A
Boyle, EM
Jarreau, PH
Kollée, L
Maier, RF
Milligan, DWA
Van Reempts, P
Weber, T
Barros, H
Gadzinowki, J
Draper, ES
Zeitlin, J
Martens, E
Martens, G
Boerch, K
Hasselager, A
Huusom, L
Pryds, O
Pokaż więcej
Temat:
PREMATURE labor
INFANT mortality
NEONATAL intensive care
PREMATURE infants
GOVERNMENT policy
MEDICAL care
PREVENTION
Źródło:
BJOG: An International Journal of Obstetrics & Gynaecology; Sep2017, Vol. 124 Issue 10, p1595-1604, 10p
Czasopismo naukowe
Szczegóły
Tytuł:
Economic costs associated with moderate and late preterm birth: a prospective population-based study.
Autorzy:
Khan, KA
Petrou, S
Dritsaki, M
Johnson, SJ
Manktelow, B
Draper, ES
Smith, LK
Seaton, SE
Marlow, N
Dorling, J
Field, DJ
Boyle, EM
Khan, K A
Johnson, S J
Draper, E S
Smith, L K
Seaton, S E
Field, D J
Boyle, E M
Pokaż więcej
Temat:
LEAVE of absence
MEDICAL care cost statistics
CHILD health services
COMMUNITY health services
GESTATIONAL age
HOSPITAL costs
LENGTH of stay in hospitals
PREMATURE infants
LONGITUDINAL method
RESEARCH funding
CASE-control method
ECONOMICS
Źródło:
BJOG: An International Journal of Obstetrics & Gynaecology; Oct2015, Vol. 122 Issue 11, p1495-1505, 11p, 3 Charts
Terminy geograficzne:
ENGLAND
Czasopismo naukowe
Szczegóły
Tytuł:
Pleural effusions are associated with adverse outcomes after cardiac surgery: a propensity-matched analysis.
Autorzy:
Schiefenhövel F; Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Institute of Medical Informatics, Charitéplatz 1, 10117, Berlin, Germany.; Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Department of Anaesthesiology and Intensive Care, Munich, Germany.; Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Institute of Artificial Intelligence and Informatics in Medicine, Munich, Germany.
Poncette AS; Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Department of Anesthesiology and Intensive Care Medicine, Charitéplatz 1, 10117, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Institute of Medical Informatics, Charitéplatz 1, 10117, Berlin, Germany.
Boyle EM; Department of Cardiothoracic Surgery, St. Charles Medical Center, Bend, OR, USA.
von Heymann C; Department of Anesthesia, Intensive Care Medicine, Emergency Medicine and Pain Therapy, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
Menk M; Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Department of Anesthesiology and Intensive Care Medicine, Charitéplatz 1, 10117, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Institute of Medical Informatics, Charitéplatz 1, 10117, Berlin, Germany.
Vorderwülbecke G; Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Department of Anesthesiology and Intensive Care Medicine, Charitéplatz 1, 10117, Berlin, Germany.
Grubitzsch H; Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Department of Cardiovascular Surgery, Augustenburger Platz 1, 13353, Berlin, Germany.
Treskatsch S; Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Department of Anesthesiology and Intensive Care Medicine, Hindenburgdamm 30, 12203, Berlin, Germany. .
Balzer F; Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Institute of Medical Informatics, Charitéplatz 1, 10117, Berlin, Germany.
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2022 Dec 07; Vol. 17 (1), pp. 298. Date of Electronic Publication: 2022 Dec 07.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Cardiac Surgical Procedures*/adverse effects
Pleural Effusion*
Humans ; Cross-Sectional Studies ; Postoperative Period
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer.
Autorzy:
Ghamlouch H; Myeloma Research Program, NYU Langone Medical Center, Perlmutter Cancer Center, 522 1st Avenue, Manhattan, New York City, NY, 10016, USA. .
Boyle EM; Myeloma Research Program, NYU Langone Medical Center, Perlmutter Cancer Center, 522 1st Avenue, Manhattan, New York City, NY, 10016, USA.
Blaney P; Myeloma Research Program, NYU Langone Medical Center, Perlmutter Cancer Center, 522 1st Avenue, Manhattan, New York City, NY, 10016, USA.; Applied Bioinformatics Laboratories (ABL), NYU Langone Medical Center, New York, NY, USA.
Wang Y; Myeloma Research Program, NYU Langone Medical Center, Perlmutter Cancer Center, 522 1st Avenue, Manhattan, New York City, NY, 10016, USA.
Choi J; Myeloma Research Program, NYU Langone Medical Center, Perlmutter Cancer Center, 522 1st Avenue, Manhattan, New York City, NY, 10016, USA.
Williams L; Myeloma Research Program, NYU Langone Medical Center, Perlmutter Cancer Center, 522 1st Avenue, Manhattan, New York City, NY, 10016, USA.
Bauer M; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Auclair D; The Multiple Myeloma Research Foundation (MMRF), Norwalk, CT, USA.
Bruno B; Myeloma Research Program, NYU Langone Medical Center, Perlmutter Cancer Center, 522 1st Avenue, Manhattan, New York City, NY, 10016, USA.
Walker BA; Division of Hematology Oncology, Indiana University, Indianapolis, IN, USA.
Davies FE; Myeloma Research Program, NYU Langone Medical Center, Perlmutter Cancer Center, 522 1st Avenue, Manhattan, New York City, NY, 10016, USA.
Morgan GJ; Myeloma Research Program, NYU Langone Medical Center, Perlmutter Cancer Center, 522 1st Avenue, Manhattan, New York City, NY, 10016, USA. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 Dec 02; Vol. 40 (1), pp. 380. Date of Electronic Publication: 2021 Dec 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
DNA-Binding Proteins/*metabolism
Multiple Myeloma/*genetics
Transcription Factors/*metabolism
Humans ; Multiple Myeloma/mortality ; Multiple Myeloma/pathology ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
Autorzy:
Renaud L; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.; Hemato-Oncology, Hôpital Saint-Louis, Paris, France.
Bossard JB; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Carpentier B; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.; Hématologie Clinique, Hôpital Saint Vincent de Paul, Lille, France.
Terriou L; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Cambier N; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.; Hématologie Clinique, Centre Hospitalier de Valenciennes, Valenciennes, France.
Chanteau G; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.; Hématologie Clinique, Centre Hospitalier de Valenciennes, Valenciennes, France.
Escure G; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Tilmont R; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Barbieux S; Hématologie Clinique, Centre Hospitalier de Dunkerque, Dunkerque, France.
Wemeau M; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.; Hématologie Clinique, Centre Hospitalier de Roubaix, Roubaix, France.
Hieulle J; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.; Hématologie Clinique, Centre Hospitalier de Roubaix, Roubaix, France.
Boyle EM; NYU Langone Healthcare, Perlmutter Cancer Center, New York, NY, USA.
Morschhauser F; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2021 Sep; Vol. 107 (3), pp. 370-373. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji:
Letter
MeSH Terms:
Adenine/*analogs & derivatives
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Central Nervous System Neoplasms/*drug therapy
Lymphoma, Large B-Cell, Diffuse/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Neoplasms, Second Primary/*drug therapy
Piperidines/*therapeutic use
Temozolomide/*therapeutic use
Adenine/therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Central Nervous System Neoplasms/mortality ; Central Nervous System Neoplasms/pathology ; Female ; Humans ; Lymphoma, Large B-Cell, Diffuse/mortality ; Lymphoma, Large B-Cell, Diffuse/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasms, Second Primary/mortality ; Neoplasms, Second Primary/pathology ; Prognosis ; Retrospective Studies ; Survival Analysis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma.
Autorzy:
Wong KY; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road, Pokfulam, Hong Kong.
Morgan GJ; NYU Langone Health, New York, NY, 10016, USA.
Boyle EM; NYU Langone Health, New York, NY, 10016, USA.
Cheng ASL; School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Yip KY; Department of Computer Science and Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Chim CS; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road, Pokfulam, Hong Kong. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Mar 26; Vol. 11 (1), pp. 7009. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cytoskeletal Proteins/*genetics
Cytoskeletal Proteins/*metabolism
DNA Methylation/*genetics
Gene Expression Regulation, Neoplastic/*genetics
Multiple Myeloma/*genetics
Cell Line, Tumor ; Cell Proliferation/genetics ; CpG Islands/genetics ; Enhancer Elements, Genetic/genetics ; Humans ; Multiple Myeloma/pathology ; Promoter Regions, Genetic/genetics ; Proof of Concept Study ; RNA Interference ; RNA, Small Interfering/genetics ; Syndecan-1/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Monitoring treatment response and disease progression in myeloma with circulating cell-free DNA.
Autorzy:
Deshpande S; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Tytarenko RG; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Wang Y; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Boyle EM; Perlmutter Cancer Center, Myeloma Research Program, NYU Langone Health, New York, NY, USA.
Ashby C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Schinke CD; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Thanendrarajan S; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Zangari M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Zhan F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Davies FE; Perlmutter Cancer Center, Myeloma Research Program, NYU Langone Health, New York, NY, USA.
Morgan GJ; Perlmutter Cancer Center, Myeloma Research Program, NYU Langone Health, New York, NY, USA.
van Rhee F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Walker BA; Division of Hematology Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, USA.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2021 Feb; Vol. 106 (2), pp. 230-240. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
Circulating Tumor DNA*
Multiple Myeloma/*genetics
Alleles ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bone Marrow ; Computational Biology/methods ; Disease Progression ; Genetic Variation ; High-Throughput Nucleotide Sequencing ; Humans ; Liquid Biopsy ; Multiple Myeloma/blood ; Multiple Myeloma/diagnosis ; Multiple Myeloma/therapy ; Prognosis ; Smoldering Multiple Myeloma/blood ; Smoldering Multiple Myeloma/diagnosis ; Smoldering Multiple Myeloma/genetics ; Smoldering Multiple Myeloma/therapy ; Treatment Outcome ; Tumor Burden ; ras Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical use.
Autorzy:
Ashby C; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA. .; Cancer Institute: Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA. .
Rutherford M; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Cancer Institute: Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Bauer MA; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Cancer Institute: Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Peterson EA; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Wang Y; Cancer Institute: Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Boyle EM; Cancer Institute: Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Wardell CP; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Cancer Institute: Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Walker BA; Division of Hematology Oncology, Indiana University, Indianapolis, IN, USA.
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2020 Apr 15; Vol. 21 (1), pp. 144. Date of Electronic Publication: 2020 Apr 15.
Typ publikacji:
Journal Article
MeSH Terms:
Software*
High-Throughput Nucleotide Sequencing/*methods
Neoplasms/*genetics
Algorithms ; Breast Neoplasms/genetics ; Female ; Gene Dosage ; Genome, Human ; Genomics ; Humans ; Lymphoma, Follicular/genetics ; Multiple Myeloma/genetics ; Mutation ; Precision Medicine ; Web Browser
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Active clearance of chest tubes is associated with reduced postoperative complications and costs after cardiac surgery: a propensity matched analysis.
Autorzy:
Baribeau Y; Department of Cardiac Surgery, New England Heart and Vascular Institute, Catholic Medical Center, 100 McGregor St, Manchester, NH, 03102, USA. .
Westbrook B; Department of Cardiac Surgery, New England Heart and Vascular Institute, Catholic Medical Center, 100 McGregor St, Manchester, NH, 03102, USA.
Baribeau Y; Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Maltais S; Department of Cardiothoracic Surgery, Centre Hospitalier Universitaire de Montréal, Montreal, Canada.
Boyle EM; Department of Thoracic Surgery, St. Charles Medical Center, Bend, OR, USA.
Perrault LP; Montreal Heart Institute, Montreal, Canada.
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2019 Nov 08; Vol. 14 (1), pp. 192. Date of Electronic Publication: 2019 Nov 08.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Cardiac Surgical Procedures*
Chest Tubes*
Drainage/*methods
Hospital Costs/*statistics & numerical data
Postoperative Complications/*prevention & control
Aged ; Drainage/economics ; Drainage/instrumentation ; Female ; Humans ; Male ; Middle Aged ; New Hampshire ; Postoperative Complications/economics ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Propensity Score ; Prospective Studies ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 33

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies